Pulmonary nodule on CT scan: what it means for patients
A pulmonary nodule is a small round area in the lung, usually less than 3 cm. The vast majority of pulmonary nodules are benign — caused by old infections, scar tissue, or calcified lymph nodes. Your radiologist will assess the nodule's size, shape, density, and your risk factors to determine whether surveillance (a follow-up CT) is needed. Most nodules under 6mm in low-risk patients need no further workup.
Discovering the words "pulmonary nodule" in your CT report is understandably alarming. The word nodule sounds serious — but the reality is that small lung nodules are extremely common findings on CT scans, and the large majority are completely benign.
Understanding what your radiologist looks at to assess a nodule will help you have a more informed conversation with your physician and reduce unnecessary anxiety.
What is a pulmonary nodule?
A pulmonary nodule is a focal, roughly round area of increased density in the lung, measuring 3 cm or less in diameter. If it is larger than 3 cm, it is called a pulmonary mass, which receives more immediate investigation.
Nodules are detected with increasing frequency as CT scan technology has become more sensitive. Studies of lung cancer screening programs find that roughly 25–50% of participants have at least one lung nodule — the vast majority of which are benign.
What causes pulmonary nodules?
Most nodules are caused by non-cancerous processes:
- Old infections — healed granulomas from prior infections like histoplasmosis, tuberculosis, or coccidioidomycosis are among the most common causes
- Calcified lymph nodes — lymph nodes that have calcified after previous infection or inflammation
- Scar tissue — from prior lung injury, surgery, or inflammation
- Hamartomas — benign tumors of mixed tissue types, often containing fat or cartilage
- Atelectasis — small areas of collapsed lung tissue that can appear nodule-like
A minority of nodules (especially larger, non-calcified nodules in smokers) represent primary lung cancer or metastatic disease — which is why follow-up is recommended for certain nodule characteristics.
How size affects the risk level
Size is the single most important factor. Current guidelines (based on the Fleischner Society recommendations, the international standard for lung nodule management) categorize nodules as follows:
These size thresholds apply to solid nodules in average-risk patients. Higher-risk patients (e.g., smokers, those with prior cancer history, significant occupational exposures) may receive more aggressive surveillance even for smaller nodules.
Solid vs. subsolid nodules
CT density also matters — and this is where CT's sensitivity becomes important:
- Solid nodule: Completely opaque on CT. Usually the result of old infection or scar tissue. Lower cancer risk per size than subsolid nodules.
- Ground glass nodule (GGN) / pure ground glass opacity: Hazy, not completely opaque — lung structures still visible through it. When persistent, these carry a higher risk of adenocarcinoma-spectrum tumors than solid nodules of the same size.
- Part-solid nodule: A mixed nodule with both solid and ground glass components. The solid component is most concerning and drives follow-up decisions.
What "follow-up CT in 3–6 months" actually means
When your radiologist recommends a follow-up CT, they are proposing surveillance — not treatment. The goal is to watch whether the nodule:
- Stays the same size — reassuring, suggests benign cause
- Grows — triggers further evaluation (biopsy, PET scan)
- Disappears — confirms it was likely an inflammatory process or infection
A nodule that remains stable for two years is generally considered benign under Fleischner guidelines and requires no further surveillance. Stable means no meaningful growth — typically defined as less than 1.5 mm change in diameter.
When to call your doctor sooner
While most nodule follow-up is not urgent, contact your physician promptly if you develop:
- New or worsening cough, especially with blood
- Unexplained weight loss
- Chest pain unrelated to injury
- Shortness of breath that is new or rapidly worsening
Want to see exactly where your nodule is in your scan?
Upload your DICOM CT files and ask your first question for free. DICOM Reader cites the exact frame where each finding appears — so you can see what your radiologist described.
Upload my CT scan — it's free to startDICOM Reader is an educational tool. It does not provide a medical diagnosis and does not replace your radiologist or physician.
Frequently asked questions
Are most pulmonary nodules cancerous?
No. The vast majority of pulmonary nodules are benign — caused by old infections, scar tissue, calcified lymph nodes, or other non-cancerous causes. In general population studies, fewer than 5% of incidentally found nodules under 8mm turn out to be malignant. The smaller and more calcified the nodule, the lower the concern.
What size pulmonary nodule is concerning?
Nodules under 6mm have very low cancer risk and often require no follow-up in low-risk patients. Nodules 6–8mm are usually monitored with follow-up CT in 6–12 months. Nodules over 8mm receive more attention — additional imaging (PET scan, CT with contrast) or biopsy may be recommended depending on your risk factors.
What does "follow-up CT in 3–6 months" mean for a nodule?
This means your radiologist wants to check whether the nodule has grown, changed shape, or remained stable. Most benign nodules stay the same size. If a nodule does not change in two years of follow-up, it is generally considered benign. Follow-up surveillance is standard practice, not a sign that cancer is expected.
What is the difference between a solid and subsolid nodule?
Solid nodules appear completely opaque on CT. Subsolid nodules (also called ground glass nodules) have a hazy appearance — either pure ground glass or part-solid (mixed). Part-solid nodules receive more careful surveillance because they have a higher risk of malignancy than pure solid nodules of the same size.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Pulmonary nodule management depends on your individual risk factors, scan characteristics, and clinical history. Always discuss your specific results with your physician or a pulmonologist.